OP0089 PHASE 2 SAFETY AND EFFICACY OF SUBCUTANEOUS (S.C.) DOSE IANALUMAB (VAY736; ANTI-BAFFR mAb) ADMINISTERED EVERY 4 WEEKS UP TO 48 WEEKS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
医学
单克隆抗体
皮下注射
内科学
免疫学
抗体
作者
Nancy Agmon‐Levin,Stanislav Ignatenko,А. В. Гордиенко,Josefina Cortés-Hernández,Pongthorn Narongroeknawin,K. Romanowska -Prochnicka,Nan Shen,Hana Ciferská,Masanari Kodera,James Cheng‐Chung Wei,Piotr Leszczyński,Joung‐Liang Lan,Eduardo Mysler,Rafał Wojciechowski,T.J. Tarr,Еlena A. Vishneva,Y. H. Chen,Yoshiteru Kaneko,Stephanie Finzel,Alberta Hoi
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
嘻嘻哈哈
mqh
极限001
学霸业
今夕何夕
aaa
朱占江
Nole
lobster
璐璐
核桃
yyy
初景
Sledge
v0id
彡沒
catcus
潇洒的惋清
阿水
皖公网安备34019202002308
